Skip to content
Medical Health Aged Care

Techcracker Lab Showcase: Breakthrough Medtech and Deep Tech at UNSW

UNSW Sydney < 1 mins read
Key Facts:

Techcracker event details

When: Friday 14 November, 2:00–5:15pm (Tech Expo and refreshments 5:15–6:30pm)

Where: Leighton Hall, John Niland Scientia Building, UNSW Kensington Campus

Cost: Free (registration essential)


UNSW Sydney and Horizons Ventures invite media to attend the Techcracker Lab showcase, a free event on Friday 14 November at UNSW’s Kensington campus.

The showcase will highlight breakthrough technologies and the visionary founders behind them, featuring live demonstrations from leading med-tech start-ups from Australia and abroad, including US-based HistoSonics, which will demonstrate its new FDA-approved histotripsy technology, a non-invasive therapy that destroys tumour tissue using pulsed sound waves.

Solina Chau, co-founder of Hong Kong-based venture capital firm Horizons Ventures and Director of the Li Ka Shing Foundation, will appear at the event alongside UNSW Chancellor David Gonski AC. The program will be hosted by Professor Bronwyn Fox AO, UNSW Deputy Vice-Chancellor (Research & Enterprise).

Speakers from Horizons Ventures' portfolio companies, including Harrison.ai, MEandMINE, Holoclara and HistoSonics, will share insights into how deep tech founders and investors navigate innovation, scale and global impact.

A key feature of Techcracker Lab is the Medtech Expo, showcasing UNSW’s most promising start-ups. As Australia’s number one university for founders, UNSW is proud to present ventures emerging from its world-class research and entrepreneurial ecosystem.


Contact details:

UNSW Sydney

Julia Holman, +61 435 124 673, [email protected]

H.S. Chau Foundation

Ryan Fung, +852 6683 1313, [email protected]

 

Media

More from this category

  • Medical Health Aged Care, Seniors Interest
  • 20/02/2026
  • 06:00
Friday, 20 February 2026 - Melbourne, Australia

AFL legend Brendan Fevola and his father speak out on painful shingles experiences, urging Aussies to take action

Former AFL star Brendan Fevolaandhisfather, Angelo,sharetheir shingles experiencesforShingles Action Week(23February –1March 2026). Almost all Australian adults carry the inactive varicella zostervirusthat causes shingles,froma previouschickenpox infection.1-3 ‘Shingles Action Week’ (23 February – 1 March 2026)refocuses Australia’s annual shingles awareness campaignon the need totakeaction,especially forthe millions ofadults agedover 50living withlong-termhealth conditionsthat can increase shingles risk, including cardiovascular disease (>3 million), diabetes (>1.1 million), asthma (>1 million) and rheumatoid arthritis (around 400,000).4 New global research*indicatesthat83% ofAustralianadults aged 50–70who areliving withlong-term healthconditions areworried shingles could disrupt everyday life, yetalmosthalf (44%)have never discussed it withtheir GP or pharmacist.1 AFLlegendBrendan Fevolaand his father, Angelo, arespeaking publicly…

  • Medical Health Aged Care
  • 20/02/2026
  • 04:11
Takeda Pharmaceutical Company Limited

Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either…

  • Contains:
  • Medical Health Aged Care
  • 19/02/2026
  • 22:11
YolTech Therapeutics

YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency

Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of YOLT-202 was well tolerated…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.